News

Milestone Achieved: Patient Enjoys Year of Seizure Freedom

Milestone Achieved: Patient Enjoys Year of Seizure Freedom

Revolutionary Seizure Management with OneRF® Technology

NeuroOne Medical Technologies Corporation is making waves in the medical technology industry with their innovative OneRF® Ablation System. This groundbreaking device has governed surgical care for patients grappling with neurological disorders, and its capabilities have recently been spotlighted by an inspiring patient story.

Patient Clara's Journey to Seizure Freedom

Clara, a pioneering patient treated with the OneRF® system, recently celebrated a remarkable milestone—she has been seizure-free for over a year. Prior to her treatment, Clara faced the daily challenge of experiencing up to ten seizures. The significant transformation in her life underscores how effective this technology can be.

After undergoing the procedure in June of the previous year, Clara's journey has been nothing short of extraordinary. She is now living a fulfilling life, enjoying new adventures like fishing and pursuing her education full-time.

The Technology Behind OneRF®

The OneRF® Ablation System is unique in the medical field, as it is the first FDA-cleared device to utilize the same stereoelectroencephalography (sEEG) electrode for both diagnostic and treatment purposes. This versatility allows clinicians to conduct monitoring, mapping, and therapeutic ablation all at the patient’s bedside. Many patients treated with the OneRF technology have seen a substantial reduction or even complete freedom from seizures.

Dave Rosa, CEO of NeuroOne, remarked, "This significant milestone validates the purpose and effectiveness of our OneRF® platform. We are excited to expand our technology for other uses, such as the upcoming OneRF® Trigeminal Nerve Ablation System, aimed at treating facial pain. We have submitted a 510(k) application to the FDA for this innovative approach, further demonstrating our commitment to advancing patient care.”

Clara's Reflections on Her Life Post-Treatment

Reflecting on her transformation, Clara shared, "Around this time last year, I was overwhelmed by multiple seizures each day. The treatment has completely changed my life. I can now participate in activities I previously couldn’t, like attending college, enjoying peaceful family dinners, and fishing. I am beyond grateful for the support and care I received." Her positivity serves as a testament to the impact of the OneRF® system.

Dr. Brin Freund, the physician overseeing Clara’s treatment, expressed optimism regarding the OneRF® Ablation System's effectiveness, noting, "Our experience with Clara reinforces the promising outcomes this technology can yield. The potential for further research and clinical applications is vast, and we are optimistic about its future.”

About NeuroOne Medical Technologies Corporation

NeuroOne is dedicated to developing cutting-edge solutions for patients with various neurological disorders. They focus on creating minimally invasive options that enhance the quality of care, including EEG monitoring, drug delivery, and brain stimulation therapies. Their commitment extends beyond epilepsy and encompasses conditions such as Parkinson’s disease, chronic pain, and mood disorders.

For more information about their products and innovations, visit the official NeuroOne website.

Frequently Asked Questions

What is the OneRF® Ablation System?

The OneRF® Ablation System is an advanced medical device that enables both diagnostic and therapeutic procedures using the same electrodes, improving surgical outcomes for patients with epilepsy.

How has Clara's life changed after treatment?

Since her procedure, Clara has been seizure-free and has been able to pursue a full-time college education and engage in recreational activities such as fishing and family outings.

What are the future applications of NeuroOne’s technology?

NeuroOne aims to expand its technology into new treatment areas, including facial pain through the upcoming OneRF® Trigeminal Nerve Ablation System.

What conditions does NeuroOne focus on treating?

The company chiefly targets neurological disorders but is also exploring treatments for conditions such as chronic pain, depression, and mood disorders.

Where can I learn more about NeuroOne’s advancements?

For detailed information, you can visit NeuroOne’s official website to explore their innovations and future projects.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cooper's Heat Pump Campaign Fuels Denver's Community

Updated Category News Views 124

How Heat Pumps Meet Philanthropy in Denver Alright, let me lay it out for you—a story as much about ingenuity as generosity. Cooper Heating & Cooling, donning their ‘Cooper Green Team’ capes, just wrapped up one heck of a community-driven campaign. They dropped a cool $5,000 into the coffers of We Don't Waste, a Denver nonprofit focused on food recovery. This...

Continue Reading
Ares Management Faces Fintech with $691B Assets

Updated Category News Views 170

Anticipation Builds: Ares Awaits TD Cowen Spotlight Ah, Ares Management, the Wall Street heavyweight clocking a colossal $691 billion in assets. Now, they’re angling to dish out some strategic insights. With the TD Cowen 2026 Financials & Fintech Conference set to roll on November 18, what’s better than watching these investment titans take the stage with their CFO...

Continue Reading
Surgery Partners and ADT Sales Under Legal Scrutiny

Updated Category News Views 6

Shareholder Scrutiny on Mergers It's no secret that corporate mergers often kick up a fuss, but when insiders get a juicy payday while regular shareholders play catch-up, folks raise eyebrows. Halper Sadeh LLC, that gutsy law firm, isn't shy about going after possible dirty deals, and they've got their eyes on a few names related to potential securities law violations and...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 61

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
Gulliver Prep's New STEAM Complex to Transform Miami

Updated Category News Views 0

Gulliver Prep Leads the Charge in Education Innovation Gulliver Preparatory School just dropped a bombshell in Miami—almost literally, with their shovels hitting the dirt for a new 95,000-square-foot STEAM complex. It's not some lip-service to educational buzzwords either. This project's part of 'The Next 100: The Centennial Campaign for Gulliver,' a mega drive to...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 52

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Real Estate Decisions in Hospitality: Buy or Lease?

Updated Category News Views 0

Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...

Continue Reading
O-I Glass Faces Class Action: What Investors Must Know

Updated Category News Views 35

The Unsettling News for O-I Glass Investors Let me dive right into this mess about O-I Glass, Inc. (NYSE:OI). If you're tangled up in their stock, you probably felt that 15.01% nosedive in your portfolio recently. That's no minor blip. On July 28, 2026, as stocks were virtually put through the shredder, O-I Glass announced they had to cut down their financial guidance for...

Continue Reading
Gilat's Revenue Dip Spurs Legal Scrutiny for Investors

Updated Category News Views 51

Gilat Satellite's Surprise Revenue Shortfall If anybody thought the satellite business was all about science fiction-esque technology, here's a reality check: when earnings don't meet expectations, shareholders get jittery. This seems to be exactly what's happening with Gilat Satellite Networks Ltd. (NASDAQ: GILT). After twice reaffirming their fiscal 2026 revenue...

Continue Reading
Insulin Delivery Devices: A Billion-Dollar Surge

Updated Category News Views 20

When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...

Continue Reading

Top 5 Most Recently Viewed Articles

Embracing AI in Recruitment: A New Era for Job Seekers

Updated Category News Views 74

The Growing Impact of AI in Recruitment In today’s competitive job market, businesses are increasingly recognizing the benefits that artificial intelligence (AI) brings to the recruitment process. A recent survey found that a substantial portion—over 60%—of job seekers feel quite at ease with AI taking charge of the recruitment process. This involvement can span...

Continue Reading
Seagate Technology's Upcoming Earnings: What Investors Should Know

Updated Category News Views 90

Seagate Technology's Earnings Report Approaches Data storage innovator Seagate Technology (NASDAQ: STX) is set to announce its earnings results imminently, presenting investors with an important opportunity to assess the company’s performance. With high expectations surrounding this earnings release, understanding the key factors that might influence the report is...

Continue Reading
Revolutionary Blood Test For Early Alzheimer's Diagnosis Unveiled

Updated Category News Views 150

Innovative Blood Test for Alzheimer's Diagnosis A groundbreaking international research initiative is currently testing a finger prick blood test to aid in diagnosing Alzheimer's disease, potentially before symptoms manifest. This trial focuses on identifying three specific proteins in the blood connected to Alzheimer's, comparing results with the traditional diagnostic...

Continue Reading
AGNC Investment Prepares for Earnings Announcement

Updated Category News Views 139

Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...

Continue Reading
Investigation Launched into Nabors Industries Merger and Fairness

Updated Category News Views 175

Overview of the Investigation on Nabors Industries Ltd. Halper Sadeh LLC, a dedicated investor rights law firm, has initiated an investigation regarding the proposed merger between Nabors Industries Ltd. (NYSE: NBR) and Parker Wellbore. The focus of this inquiry is to determine whether the terms of this merger are fair to the shareholders of Nabors Industries. This...

Continue Reading